Supplementary Figure 1 from Phase I Study of Bosutinib, a Src/Abl Tyrosine Kinase Inhibitor, Administered to Patients with Advanced Solid Tumors

Authors :: Wells A. Messersmith
Charles Zacharchuk
Kathleen Turnbull
Eric Leip
Poe-Hirr Hsyu
Nathalie Bardy-Bouxin
Shefali Agarwal
Richat Abbas
Gregory M. Springett
Elena G. Chiorean
Philip J. Gold
Mitesh J. Borad
Barbara J. Gitlitz
Mansoor N. Saleh
Smitha S. Krishnamurthi
Adil I. Daud
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 89K

Tools